458 related articles for article (PubMed ID: 35547755)
1. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
[TBL] [Abstract][Full Text] [Related]
2. Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.
Pham TC; Jayasinghe MK; Pham TT; Yang Y; Wei L; Usman WM; Chen H; Pirisinu M; Gong J; Kim S; Peng B; Wang W; Chan C; Ma V; Nguyen NTH; Kappei D; Nguyen XH; Cho WC; Shi J; Le MTN
J Extracell Vesicles; 2021 Feb; 10(4):e12057. PubMed ID: 33643546
[TBL] [Abstract][Full Text] [Related]
3. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-Loaded Extracellular Vesicles Functionalized with Therapeutic and Targeted Peptides for the Treatment of Glioblastoma Multiforme.
Ye Z; Zhang T; He W; Jin H; Liu C; Yang Z; Ren J
ACS Appl Mater Interfaces; 2018 Apr; 10(15):12341-12350. PubMed ID: 29564886
[TBL] [Abstract][Full Text] [Related]
5. Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery.
Meng W; Wang L; Du X; Xie M; Yang F; Li F; Wu ZE; Gan J; Wei H; Cao C; Lu S; Cao B; Li L; Li L; Zhu G
J Control Release; 2023 Nov; 363():235-252. PubMed ID: 37739016
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles as an Efficient and Versatile System for Drug Delivery.
Dang XTT; Kavishka JM; Zhang DX; Pirisinu M; Le MTN
Cells; 2020 Sep; 9(10):. PubMed ID: 33003285
[TBL] [Abstract][Full Text] [Related]
7. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
[TBL] [Abstract][Full Text] [Related]
8. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
Ahmadi M; Hassanpour M; Rezaie J
Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
[TBL] [Abstract][Full Text] [Related]
9. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery.
Mohammadi AH; Ghazvinian Z; Bagheri F; Harada M; Baghaei K
BioDrugs; 2023 May; 37(3):353-374. PubMed ID: 37093521
[TBL] [Abstract][Full Text] [Related]
10. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery.
Ilahibaks NF; Ardisasmita AI; Xie S; Gunnarsson A; Brealey J; Vader P; de Jong OG; de Jager S; Dekker N; Peacock B; Schiffelers RM; Sluijter JPG; Lei Z
J Control Release; 2023 Mar; 355():579-592. PubMed ID: 36746337
[TBL] [Abstract][Full Text] [Related]
11. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
Nasiri Kenari A; Cheng L; Hill AF
Methods; 2020 May; 177():103-113. PubMed ID: 31917274
[TBL] [Abstract][Full Text] [Related]
12. Engineering Extracellular Vesicles to Target Pancreatic Tissue
Komuro H; Kawai-Harada Y; Aminova S; Pascual N; Malik A; Contag CH; Harada M
Nanotheranostics; 2021; 5(4):378-390. PubMed ID: 33912378
[TBL] [Abstract][Full Text] [Related]
13. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
[TBL] [Abstract][Full Text] [Related]
14. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
[TBL] [Abstract][Full Text] [Related]
15. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
Ingato D; Lee JU; Sim SJ; Kwon YJ
J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
Wu M; Wang M; Jia H; Wu P
Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
19. CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia.
Chen H; Jayasinghe MK; Yeo EYM; Wu Z; Pirisinu M; Usman WM; Pham TT; Lim KW; Tran NV; Leung AYH; Du X; Zhang Q; Phan AT; Le MTN
Cell Prolif; 2022 Sep; 55(9):e13255. PubMed ID: 35851970
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
